TVTX
Travere Therapeutics, Inc. (TVTX) Scenario Analysis Analysis (2026)
Overall Score
Base Case
TVTX remains a high-burn, pre-profitability profile with negative TTM margins and a very high EV/Sales multiple, so the base case still assumes execution risk remains elevated.
Liquidity is adequate in the near term with a current ratio above 4.0 and cash per share of 5.23, but leverage remains heavy with debt-to-equity at 25.16x and interest coverage still negative.
Bull Case
A bull scenario still depends on meaningful operating leverage from the company’s very high gross margin profile (94.4%) translating into sustained margin expansion.
If revenue growth accelerates and cash burn narrows, the current balance-sheet liquidity could support a rerating from today’s elevated valuation base.
Bear Case
The bear case remains centered on persistent losses, weak returns on capital, and a negative interest coverage ratio, which could pressure the equity if execution slips.
With EV/FCF still extremely elevated and profitability still negative, any slowdown in growth or funding pressure would likely compress the multiple further.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Travere Therapeutics, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

